MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV
批准号:
6453667
负责人:
TOSHIAKI KODAMA
金额:
$11.11万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-05-01 至 2002-04-30
中文摘要
虽然已知HIV-1 V3在确定病毒细胞中是重要的,
嗜性和辅助受体的使用,对SIV的作用知之甚少
V3. 本研究的目的是探讨
SIV V3用于病毒细胞嗜性和辅助受体使用。 本研究
使用了三种具有不同细胞向性的分子克隆SIV,
共受体用途和V3序列T细胞嗜性SIVmacEvT 3,使用
CXCR 4作为辅助受体,使用CCR 5的人T细胞系嗜性SIVmac 239,
和使用CCR 5的嗜巨噬细胞SIVmacEvM 3。 我们交换了V3
每个克隆的SIV序列与其他克隆的序列一起构建
V3重组病毒。 我们从V3重组体中获得的数据表明,
表明每种SIV的细胞嗜性和辅助受体的使用是
主要由V3序列决定。 位点特异性诱变
研究进一步证明氨基酸的电荷
在SIV V3序列中起着重要的作用,
病毒细胞嗜性和核心受体的使用。 这表明
SIV的V3序列的电荷,像HIV-1的那些,有助于
在gp 120中形成辅助受体结合位点,其可能含有
V3区或受其构象影响。有趣的是,
一些构建的突变病毒可以同时使用CXCR 4和CCR 5
类似于双嗜性HIV-1。 自从EvT 3使用
CXCR 4,而不是239使用CCR 5,诱导快速和严重的CD 4 + T细胞
在恒河猴中,重要的是要检查
双嗜性SIV在体内的致病潜力。 的进一步研究
使用辅助受体特异性SIV克隆的恒河猴模型,
利用CXCR 4、CCR 5或CXCR 4和CCR 5将提供重要的
信息,以更好地了解
艾滋病患者HIV-1辅助受体从CCR 5变为CXCR 4 资金
NIH RR 00163(项目2)出版物Martin K,哈根S,Kodama T.
SIV CXCR 4使用的遗传决定因素:V1和V3的作用
序列的 在第16届非人类灵长类动物模型年会上,
艾滋病(亚特兰大,佐治亚州,1998年10月7日至10日)(摘要3)。
英文摘要
While HIV-1 V3 is known to be important in determining viral cell
tropism and coreceptor usage, little is known about the role of SIV
V3. The objective of this study is to investigate the significance of
SIV V3 for viral cell tropism and coreceptor usage. In this study, we
have used three molecularly cloned SIV with distinct cell tropisms,
coreceptor usages and the V3 sequences T cell-tropic SIVmacEvT3 using
CXCR4 as a coreceptor, human T cell line-tropic SIVmac239 using CCR5,
and macrophage-tropic SIVmacEvM3 using CCR5. We have exchanged V3
sequences of each cloned SIV with those of other clones to construct
V3 recombinant viruses. Our data obtained from V3 recombinants have
shown that the cell tropism and coreceptor usage of each SIV are
primarily determined by the V3 sequences. Site-specific mutagenesis
studies have further demonstrated that the charge of the amino acids
within SIV V3 sequences plays an important role in determining the
viral cell tropisms an d corecep tor usage. This suggests that the
charge of V3 sequences of SIV, like those of HIV-1, contributes to the
formation of coreceptor binding sites in gp120, which may contain the
V3 region or be conformationally influenced by it. Interestingly,
some of the constructed mutant viruses could use both CXCR4 and CCR5
for virus entry, similar to dual-tropic HIV-1. Since EvT3 using
CXCR4, but not 239 using CCR5, induces rapid and severe CD4+ T cell
depletion in rhesus macaques, it will be important to examine the
pathogenic potential of dual-tropic SIV in vivo. Further studies with
the rhesus macaque model using coreceptor-specific SIV clones that
utilize CXCR4, CCR5 or CXCR4 and CCR5 will provide important
information to better understand the mechanisms and significance of
HIV-1 coreceptor changes from CCR5 to CXCR4 in AIDS patients. FUNDING
NIH RR00163 (Project 2) PUBLICATIONS Martin K, Hagen S, Kodama T.
Genetic determinants of SIV CXCR4 usage the role of V1 and V3
sequences. In 16th Annual Symposium on Nonhuman Primate Models for
AIDS (held in Atlanta, GA, October 7-10, 1998) (abstract 3).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SIV CORECEPTOR USAGE DETERMINES CD4+ T CELL DEPLETION
-
批准号:6592292
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV
-
批准号:6592291
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+ T CELL DEPLETION
-
批准号:6453668
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
Pathogenic Conversion of Attenuated SIV D nef
-
批准号:6632497
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
Pathogenic Conversion of Attenuated SIV D nef
-
批准号:6747336
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
Pathogenic Conversion of Attenuated SIV D nef
-
批准号:6408006
-
项目类别:
-
资助金额:$31.31万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
Pathogenic Conversion of Attenuated SIV D nef
-
批准号:6511643
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+ T CELL DEPLETION
-
批准号:6116114
-
项目类别:
-
资助金额:$14.76万
-
财政年份:1999
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV
-
批准号:6116113
-
项目类别:
-
资助金额:$14.76万
-
财政年份:1999
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIGNIFICANCE OF SIV CELL SPECIFICITY FOR AIDS DISEASE PROCESSES
-
批准号:6277345
-
项目类别:
-
资助金额:$18.45万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:2542928
-
项目类别:
-
资助金额:$24.96万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:6399607
-
项目类别:
-
资助金额:$26.46万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:2887674
-
项目类别:
-
资助金额:$25.71万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:6373779
-
项目类别:
-
资助金额:$27.28万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:6510794
-
项目类别:
-
资助金额:$28.02万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:6170760
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGIONS OF SIV
-
批准号:6277346
-
项目类别:
-
资助金额:$18.45万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR BASIS OF SIV NEUROPATHOGENESIS: HIV
-
批准号:6247194
-
项目类别:
-
资助金额:$18.46万
-
财政年份:1997
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIGNIFICANCE OF SIV CELL SPECIFICITY FOR AIDS DISEASE PROCESSES
-
批准号:6247195
-
项目类别:
-
资助金额:$18.46万
-
财政年份:1997
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV: AIDS
-
批准号:6247196
-
项目类别:
-
资助金额:$18.46万
-
财政年份:1997
-
负责人:TOSHIAKI KODAMA
-
依托单位:
海外基金